Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status

NCT03002220 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: radium-223

Sponsor

MedSIR

Collaborators

[object Object]